Document Detail


Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.
MedLine Citation:
PMID:  17390135     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate the usefulness of PET/CT in melanoma patients with an elevated serum S-100B tumour marker level. METHODS: Out of 165 consecutive high-risk melanoma patients referred for PET/CT imaging, 47 had elevated (>0.2 microg/l) S-100B serum levels and a contemporaneous 18F-FDG PET/CT scan. PET/CT scans were evaluated for the presence of metastases. To produce a composite reference standard, we used cytological, histological, MRI and PET/CT follow-up findings as well as clinical and S-100B follow-up. RESULTS: Among the 47 patients with increased S-100B levels, PET/CT correctly identified metastases in 38 (30 distant metastases and eight lymph node metastases). In one patient with cervical lymph node metastases, PET/CT was negative. Eight patients had no metastases and PET/CT correctly excluded metastases in all of them. Overall sensitivity for metastases was 97% (38/39), specificity 100% (8/8) and accuracy 98% (46/47). S-100B was significantly higher in patients with distant metastases (mean 1.93 microg/l, range 0.3-14.3 microg/l) than in patients with lymph node metastases (mean 0.49 microg/l, range 0.3-1.6 microg/l, p=0.003) or patients without metastases (mean 0.625 microg/l, range 0.3-2.6 microg/l, p=0.007). However, 6 of 14 patients with a tumour marker level of 0.3 microg/l had no metastases. CONCLUSION: In melanoma patients with elevated S-100B tumour marker levels, FDG-PET/CT accurately identifies lymph node or distant metastases and reliably excludes metastases. Because of the significant number of false positive S-100B tumour marker determinations (17%), we recommend repetition of tumour marker measurements if elevated S-100B levels occur before extensive imaging is used.
Authors:
Klaus Strobel; Jeannine Skalsky; Victor Kalff; Katrin Baumann; Burkhardt Seifert; Helen Joller-Jemelka; Reinhard Dummer; Hans C Steinert
Related Documents :
17384505 - Preoperative imaging staging of rectal cancer.
16220355 - Performance of 2-deoxy-2-[f-18]fluoro-d-glucose positron emission tomography and integr...
18186915 - Multimodality approach of perioperative 18f-fdg pet/ct imaging, intraoperative 18f-fdg ...
17036525 - Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomogr...
22412225 - Accuracy of automated attenuation-based 3-dimensional segmentation: in the analysis of ...
19026005 - Fid sampling superior to spin-echo sampling for t2*-based quantification of holmium-loa...
Publication Detail:
Type:  Journal Article     Date:  2007-03-28
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  34     ISSN:  1619-7070     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-23     Completed Date:  2008-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1366-75     Citation Subset:  IM    
Affiliation:
Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. klaus.strobel@usz.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
False Positive Reactions
Female
Fluorodeoxyglucose F18 / pharmacology*
Humans
Male
Melanoma / blood*,  diagnosis,  therapy*
Middle Aged
Neoplasm Metastasis
Positron-Emission Tomography / methods*
Tomography, X-Ray Computed / methods*
Tumor Markers, Biological
Whole Body Imaging
Chemical
Reg. No./Substance:
0/Tumor Markers, Biological; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A direct ROI quantification method for inherent PVE correction: accuracy assessment in striatal SPEC...
Next Document:  Clues about the ancestral roles of plant MADS-box genes from a functional analysis of moss homologue...